Literature DB >> 11358771

Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study.

D M Coulter1, A Bate, R H Meyboom, M Lindquist, I R Edwards.   

Abstract

OBJECTIVES: To examine the relation between antipsychotic drugs and myocarditis and cardiomyopathy.
DESIGN: Data mining using bayesian statistics implemented in a neural network architecture.
SETTING: International database on adverse drug reactions run by the World Health Organization programme for international drug monitoring. MAIN OUTCOME MEASURES: Reports mentioning antipsychotic drugs, cardiomyopathy, or myocarditis.
RESULTS: A strong signal existed for an association between clozapine and cardiomyopathy and myocarditis. An association was also seen with other antipsychotics as a group. The association was based on sufficient cases with adequate documentation and apparent lack of confounding to constitute a signal. Associations between myocarditis or cardiomyopathy and lithium, chlorpromazine, fluphenazine, haloperidol, and risperidone need further investigation.
CONCLUSIONS: Some antipsychotic drugs seem to be linked to cardiomyopathy and myocarditis. The study shows the potential of bayesian neural networks in analysing data on drug safety.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11358771      PMCID: PMC31617          DOI: 10.1136/bmj.322.7296.1207

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  8 in total

Review 1.  Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.

Authors:  J Geddes; N Freemantle; P Harrison; P Bebbington
Journal:  BMJ       Date:  2000-12-02

2.  Quality criteria for early signals of possible adverse drug reactions.

Authors:  I R Edwards; M Lindquist; B E Wiholm; E Napke
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

3.  A Bayesian neural network method for adverse drug reaction signal generation.

Authors:  A Bate; M Lindquist; I R Edwards; S Olsson; R Orre; A Lansner; R M De Freitas
Journal:  Eur J Clin Pharmacol       Date:  1998-06       Impact factor: 2.953

4.  The role of the WHO programme on International Drug Monitoring in coordinating worldwide drug safety efforts.

Authors:  S Olsson
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606

5.  Adverse drug reactions: finding the needle in the haystack.

Authors:  I R Edwards
Journal:  BMJ       Date:  1997-08-30

6.  Myocarditis and cardiomyopathy associated with clozapine.

Authors:  J G Kilian; K Kerr; C Lawrence; D S Celermajer
Journal:  Lancet       Date:  1999-11-27       Impact factor: 79.321

Review 7.  Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry.

Authors:  G Honigfeld; F Arellano; J Sethi; A Bianchini; J Schein
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

8.  [Allergic myocarditis in clozapine treatment].

Authors:  V E Jensen; O Gøtzsche
Journal:  Ugeskr Laeger       Date:  1994-07-11
  8 in total
  38 in total

Review 1.  Quantitative methods in pharmacovigilance: focus on signal detection.

Authors:  Manfred Hauben; Xiaofeng Zhou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 2.  Application of data mining techniques in pharmacovigilance.

Authors:  Andrew M Wilson; Lehana Thabane; Anne Holbrook
Journal:  Br J Clin Pharmacol       Date:  2004-02       Impact factor: 4.335

Review 3.  Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.

Authors:  Karine Titier; Pierre-Olivier Girodet; Hélène Verdoux; Mathieu Molimard; Bernard Bégaud; Wilhelm Haverkamp; Malcolm Lader; Nicholas Moore
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 4.  Monitoring for adverse drug reactions.

Authors:  J J Coleman; R E Ferner; S J W Evans
Journal:  Br J Clin Pharmacol       Date:  2006-04       Impact factor: 4.335

5.  Atypicality of atypical antipsychotics.

Authors:  Andrew Farah
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

Review 6.  Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

Authors:  Domenico De Berardis; Gabriella Rapini; Luigi Olivieri; Domenico Di Nicola; Carmine Tomasetti; Alessandro Valchera; Michele Fornaro; Fabio Di Fabio; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Ther Adv Drug Saf       Date:  2018-02-06

7.  Impact of stratification on adverse drug reaction surveillance.

Authors:  Johan Hopstadius; G Niklas Norén; Andrew Bate; I Ralph Edwards
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

8.  Detection of signals of abuse and dependence applying disproportionality analysis.

Authors:  V Pauly; M Lapeyre-Mestre; D Braunstein; M Rueter; X Thirion; E Jouanjus; J Micallef
Journal:  Eur J Clin Pharmacol       Date:  2014-11-20       Impact factor: 2.953

Review 9.  Heart failure induced by non-cardiac drugs.

Authors:  Lars Slørdal; Olav Spigset
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

10.  Could it be Quetiapine-induced Peripartum Cardiomyopathy?

Authors:  Mandeep Kaler; Rameen Shakur; Hazel I Learner; Andrew Deaner; Richard J Howard
Journal:  Obstet Med       Date:  2013-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.